May 17, 2024

TORONTO, May 17, 2024 /PRNewswire/ — Visionary Holdings Inc. (the “Company”) (NASDAQ: GV), a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries in Canada and market partners in China, today announced the Company and Red Sun Group, a top 500 company in China, are collaborating to jointly invest in establishing a life sciences industry conglomerate in Toronto. This initiative aims to contribute globally to achieving the mission of “health, happiness, beauty, and longevity” for humanity, making it a top contributor in preventive medicine and natural medicine. Visionary Group and Red Sun Group, a top 500 company in China, are collaborating to jointly invest in establishing a life sciences industry conglomerate in Toronto. This conglomerate aims to become the world’s largest platform for nicotinamide (whitening) and anti-aging NMN (nicotinamide mononucleotide) industries. Leveraging Red Sun Group’s globally leading nicotinamide and NMN raw material base and technological platform, Visionary Group plans to establish a complete industry chain business system from raw materials to functional foods, skincare products, functional animal health products, and future medical terminal products. These products serve global cosmetics, food manufacturing, animal products, pharmaceutical, and medical institutions, as well as end customers. Harvard University scientist David Sinclair confirms the life-extending effect of NMN Visionary Group cooperates with Red Sun Group, a Fortune 500 company in China, to establish a cooperation project of a life science industry group in Toronto, which has the core of the health care industry: 1. Biotechnology innovation and bio-patented technology:Red Sun Group has the world’s leading nicotine and NMN raw material production and technology platforms, and can provide high-quality products through innovation, which is important for promoting the life science industry and related functionalities The development of food and health products is crucial. 2. Capabilities and conditions for high cross-border integration of the health industry chain:By establishing a complete industrial chain from raw materials to final products, we can not only enhance the competitiveness of high-quality products, but also fully control production costs and quality, thereby more effectively meeting global and global needs. Canada’s vast market demand. 3. Accurate target market demand positioning and expansion:The group’s products serve many fields such as cosmetics, food manufacturing, animal products, pharmaceuticals and medical institutions. Its diversified market positioning helps expand the target market and customer base to increase market share. 4. Global trends and health needs:Anti-aging and whitening products are in line with the current demand trends of global consumers, especially for customer groups who pursue healthy quality of life and appearance care. This can ensure the core value and continued sustainability of the products in the market need. 5. Transnational research and development (R&D):Companies invest in research and development of new products and technologies, which not only helps maintain product innovation and competitiveness, but is also a key factor in stabilizing and expanding market positions. 6. Sino-Canadian international cooperation:This kind of transnational cooperation is essential for strengthening international business relations and expanding global markets, and can also enhance the international image of corporate brands. 7. Sustainability contributes to human health and positive corporate social responsibility:Corporate behavior consistent with sustainable development increases the company’s awareness of the environment and its investment in social responsibility, which helps enhance the corporate image and attract investors . Cross-border cooperation projects can bring high-growth opportunities driven by biotechnology innovation to participating group companies, and have the potential to shape the future global trends in related health industries. NMN Nicotinamide Mononucleotide Market Size and ForecastThe nicotinamide mononucleotide market size is US$5 billion in 2023 and is expected to reach US$12.93 billion by 2031, with a compound annual growth rate from 2024 to 2031 of 9.1%. and play an important role in the market. Nicotinamide mononucleotide (NMN)’s potential health benefits and growing use in the anti-aging and longevity fields are driving the phenomenal growth of the market. Nicotinamide adenine dinucleotide (NMN) is the precursor of NAD+ and is essential for cellular energy synthesis and DNA repair processes. Research on the importance of NMN in supporting cellular resiliency and health continues, generating strong interest from customers looking for longevity solutions. Furthermore, the market for NMN supplements is growing and is expected to continue to grow in the foreseeable future due to factors such as the aging world population and people’s desire for a better lifestyle. Nicotinamide mononucleotide (NMN) market is expanding owing to many important parameters. First, growing consumer awareness of NMN’s possible anti-aging and life-extending effects is driving demand for NMN supplements. Secondly, more and more studies have demonstrated the function of NMN in DNA repair pathways and cellular energy metabolism, encouraging its use in the health and wellness industry. Thirdly, the market is growing as age-related diseases are becoming more common as the elderly population is seeking preventive healthcare measures. Additionally, endorsements from celebrities and medical professionals have further enhanced consumer confidence in NMN supplements, thereby driving market expansion. As the search for healthy aging solutions continues to heat up, there is still plenty of room for growth in the NMN market. Mechanism of Action of NMN Increased Nicotinamide Mononucleotide (NMN), a precursor to NAD, promotes axonal regeneration post-injury. NMN exhibits novel physiological functions in mammals, unveiling unexpected links between cancer chemotherapy strategies and axonal disease treatments. NMN has novel physiological functions in mammals and reveals unexpected connections between new strategies for cancer chemotherapy and the treatment of axonopathies . Reverse Aging: Harvard Scientist Dr. David Sinclair on NMN and Anti-Aging Supplements https://youtu.be/o6hEHPjIHOI Dynamic of Nicotinamide Mononucleotide (NMN) Market   Market Drivers:   Rising consumer awareness of anti-aging benefits: Increasing consumer awareness of the potential anti-aging benefits of NMN is driving demand for NMN supplements.   Extensive research supports NMN’s health benefits: Extensive scientific research emphasizes NMN’s role in cellular energy metabolism and DNA repair mechanisms, driving its adoption in the health and wellness sector.   Increasing prevalence of age-related diseases: The increasing prevalence of age-related diseases, coupled with global population aging, is driving demand for preventive healthcare measures (including NMN supplements).   Endorsement from healthcare professionals and celebrities: Endorsement and recommendations from healthcare professionals and celebrities are enhancing consumer confidence in NMN supplements,